The diagnostic landscape for Alzheimer's disease is shifting fast. Blood-based biomarkers are moving from research curiosity to clinical reality, but adoption comes with real challenges. Join our webinar to hear directly from leading regional experts on what's clinically actionable today and what's coming next.
Downloadable Slides:
Professor Yates
Professor Chen
Professor Kandiah
